[1]韩 瑞.熊去氧胆酸联合布地奈德治疗原发性胆汁性肝硬化效果及对患者血清总超氧化物歧化酶、丙二醛水平的影响[J].陕西医学杂志,2019,(7):942-944,封3.
　HAN Rui..Effect of ursodeoxycholic acid combined with budesonide on the treatment of primary biliary cirrhosis and the levels of serum T-SOD and MDA[J].,2019,(7):942-944,封3.
点击复制

熊去氧胆酸联合布地奈德治疗原发性胆汁性肝硬化效果及对患者血清总超氧化物歧化酶、丙二醛水平的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年7期
页码:
942-944,封3
栏目:
药物与临床
出版日期:
2019-07-05

文章信息/Info

Title:
Effect of ursodeoxycholic acid combined with budesonide on the treatment of primary biliary cirrhosis and the levels of serum T-SOD and MDA
文章编号:
DOI:10.3969/j.issn.1000-7377.2019.07.037
作者:
韩 瑞
青海省交通医院普外科（西宁 811100）
Author(s):
HAN Rui.
Department of General Surgery,Qinghai Transportation Hospital(Xining 811100)
关键词:
熊去氧胆酸; 布地奈德; 原发性胆汁性肝硬化; 总超氧化物歧化酶; 丙二醛; 影响
Keywords:
Key words Ursodeoxycholic acid; Budesonide; Primary biliary cirrhosis; Total superoxide dismutase; Malondialdehyde; Influences
分类号:
R657.31
文献标志码:
A
摘要:
摘 要 目的：探究熊去氧胆酸（UDCA）联合布地奈德对原发性胆汁性肝硬化（PBC）的治疗效果及对PBC患者血清总超氧化物歧化酶（T-SOD）及丙二醛（MDA）水平的影响。方法：选取 78例PBC患者为研究对象，按照随机数字表法将其均分为观察组与对照组，每组各39例患者，而后对照组单纯使用UDCA进行治疗，观察组在对照组基础上加用布地奈德，治疗时间均为48周，而后于治疗第16周、第32周及第48周对治疗效果进行评估，对肝功能进行实验室检查，并对两组患者氧化应激血清因子进行测量。结果：①治疗前两组症状评分比较差异不具有统计学意义（P＞0.05），治疗第10周、第20周、第30周及第48周观察组得分低于对照组，两组比较差异具有统计学意义（P＜0.05）；②治疗前两组肝功能指标谷丙转氨酶（ALT）、谷草转氨酶（AST）、碱性磷酸酶（ALP）比较差异不具有统计学意义（P＞0.05），治疗后两组上述指标均出现下降，观察组低于对照组（P＜0.05）；③治疗前两组MDA及T-SOD水平差异不具有统计学意义（P＞0.05），治疗后MDA出现下降，T-SOD出现上升，观察组MDA高于对照组，T-SOD低于对照组，差异具有统计学意义（P＜0.05）。结论：UDCA能够显著改善PBC临床症状，同时改善其肝功能及氧化应激状态。
Abstract:
Abstract Objective: To investigate the therapeutic effect of ursodeoxycholic acid (UDCA) combined with budesonide on primary biliary cirrhosis (PBC) and on the serum total superoxide dismutase (T -SOD) and malondialdehyde (MDA).Methods:78 cases of PBC patients as the research object，according to the random number table method were divided into experimental group and control group，39 cases in each group patients were then treated with UDCA alone in the control group. Budesonide was given to the experimental group on the basis of the control group for 48 weeks，and then the therapeutic effect was evaluated at the 16th week，the 32nd week and the 48th week，Liver function laboratory tests，and two groups of patients with oxidative stress serum factor measurement. Results: ①There was no significant difference in symptom scores between the two groups before treatment (P＞0.05). The scores of the experimental group at the 10th，20th，30th and 48th week after treatment were lower than those in the control group (P＜0.05)；②There was no significant difference in ALT，AST and ALP between the two groups before treatment (P＞0.05) The levels of MDA and T-SOD in the two groups before treatment were not significantly different (P＞0.05). After the treatment，MDA (P＜0.05). There was a significant decrease in T-SOD，T-SOD in experimental group was higher than that in control group，and T-SOD was lower than that in control group.Conclusion: UDCA can significantly improve the clinical symptoms of PBC，while improving its liver function and oxidative stress status.

参考文献/References:

[1] Granito A,Muratori P,Quarneti C,et al.Antinuclear antibodies as ancillary markers in primary biliary cirrhosis[J].Expert Review of Molecular Diagnostics,2012,12(1):65-74. [2] 何方平,陈 兰.原发性胆汁性肝硬化的流行病学及自然病程研究进展[J].实用肝脏病杂志,2013,16(2):97-98. [3] Heathcote EJ.Management of primary biliary cirrhosis.The american association for the study of liver diseases practice guidelines[J].Hepatology,2000,31(4):1005. [4] 朱艳冬.194例原发性胆汁性肝硬化患者的临床分析[D].吉林大学,2014. [5] 王 燕,陆伦根.氧化应激在胆汁淤积中的作用[J].肝脏,2012,17(7):501-503. [6] 王贵阳,李可为.氧化应激在胆汁淤积性肝损伤中的作用及抗氧化治疗研究进展[J].中国现代普通外科进展,2014,17(1):38-41. [7] 南海峰.熊去氧胆酸治疗原发性胆汁性肝硬化的临床观察[J].中国卫生标准管理,2016,7(9):106-107. [8] 徐 骅,杨 莉,应海峰,等.中药联合熊去氧胆酸治疗原发性胆汁性肝硬化临床观察[J].中医药学报,2015.43(4):98-100. [9] 姚定康.布地奈德联合熊去氧胆酸治疗原发性胆汁性肝硬化的临床观察\[C\]//中华医学会第十六次全国病毒性肝炎及肝病学术会议论文汇编,2013. [10] 周新源,田耀洲.难治性原发性胆汁性肝硬化治疗进展[J].吉林中医药,2014,34(11):1185-1188.

相似文献/References:

[1]杨明珠,韩改琳,倪 莉.布地奈德联合阿奇霉素序贯疗法对肺炎支原体肺炎患儿血清TNFα、CRP、IL5及VEGF的影响研究[J].陕西医学杂志,2019,(3):383.
[2]李建玲,冯小宝△.布地奈德联合鼻内镜手术治疗鼻窦炎鼻息肉疗效及对患者鼻腔功能的影响*[J].陕西医学杂志,2019,(11):1548.
　LI Jianling,FENG Xiaobao..Therapeutic effect of budesonide combined with endoscopic surgery on sinusitisnasal polyps and its effect on nasal function[J].,2019,(7):1548.
[3]王新伟,杨道坤△,梁海军,等.熊去氧胆酸对慢性乙型肝炎患者NAs抗病毒治疗后肝功能异常修复的临床研究*[J].陕西医学杂志,2020,49(1):112.
[4]胡 伟.布地奈德雾化吸入治疗新生儿肺炎临床效果及对患儿各项潮气呼吸指标的影响研究[J].陕西医学杂志,2021,50(3):353.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.025]
　HU Wei.Therapeutic effect of budesonide aerosol inhalation in treatment of neonatal pneumonia and its influence on tidal breathing indexes and adverse reactions[J].,2021,50(7):353.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.025]

更新日期/Last Update: 2019-07-12